Russell Investments Group
RCUS icon

Russell Investments Group’s Arcus Biosciences RCUS Stock Holding History

Russell Investments Group’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51M Buy
81,549
+716
+0.9% +$17.7K ﹤0.01% 1950
2026
Q1 		$1.75M Sell
80,833
-55,288
-41% -$1.19M ﹤0.01% 1943
2025
Q4 		$3.24M Buy
136,121
+53,892
+66% +$1.1M ﹤0.01% 1592
2025
Q3 		$1.12M Buy
82,229
+34,263
+71% +$356K ﹤0.01% 2159
2025
Q2 		$390K Sell
47,966
-48,758
-50% -$416K ﹤0.01% 2437
2025
Q1 		$759K Buy
96,724
+66,771
+223% +$774K ﹤0.01% 2150
2024
Q4 		$446K Buy
29,953
+19,543
+188% +$319K ﹤0.01% 2307
2024
Q3 		$159K Buy
10,410
+9,924
+2,042% +$156K ﹤0.01% 2561
2024
Q2 		$7.4K Buy
486
+476
+4,760% +$7.68K ﹤0.01% 3142
2024
Q1 		$189 Sell
10
-15,865
-100% -$274K ﹤0.01% 3279
2023
Q4 		$303K Buy
15,875
+45
+0.3% +$719 ﹤0.01% 2344
2023
Q3 		$284K Sell
15,830
-1,270
-7% -$25.5K ﹤0.01% 2410
2023
Q2 		$347K Sell
17,100
-11,105
-39% -$211K ﹤0.01% 2336
2023
Q1 		$514K Buy
28,205
+23,905
+556% +$457K ﹤0.01% 2250
2022
Q4 		$88.9K Buy
+4,300
New +$118K ﹤0.01% 2687
2021
Q3 		– Sell
-10,540
Closed -$287K – 3179
2021
Q2 		$287K Sell
10,540
-658
-6% -$18.8K ﹤0.01% 2795
2021
Q1 		$314K Buy
+11,198
New +$390K ﹤0.01% 2698
2020
Q3 		– Sell
-8,100
Closed -$200K – 3241
2020
Q2 		$200K Buy
+8,100
New +$219K ﹤0.01% 2711
2020
Q1 		– Sell
-20,600
Closed -$207K – 3120
2019
Q4 		$207K Sell
20,600
-715
-3% -$6.01K ﹤0.01% 2703
2019
Q3 		$195K Buy
21,315
+5,278
+33% +$42.4K ﹤0.01% 2618
2019
Q2 		$128K Buy
+16,037
New +$161K ﹤0.01% 2604

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Russell Investments Group's RCUS Position: Q2 2026 in Review

Russell Investments Group increased its Arcus Biosciences (RCUS) stake by 0.89% in Q2 2026, buying an estimated $17.7K and bringing the position to 81,549 shares worth $2.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1950.

Russell Investments Group first reported a position in RCUS in Q2 2019 and has held it in 21 quarters since. The position peaked at $3.24M in Q4 2025. 79 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Russell Investments Group held 81,549 shares of Arcus Biosciences worth $2.51M as of Q2 2026.
  • Russell Investments Group bought 716 Arcus Biosciences shares in Q2 2026, an estimated $17.7K.
  • Arcus Biosciences made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1950 holding.
  • Russell Investments Group first reported a position in Arcus Biosciences in Q2 2019 and has held it in 21 quarters since.
  • Russell Investments Group's Arcus Biosciences position peaked at $3.24M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.